NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests
NeoGenomics launched its PanTracer Family of genomic profiling tests and Paletrra, an AI-driven spatial proteomics platform.
Read More
Search Results for: lung cancer
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.
Read More
Oncologists: More Advanced Cancers, Current Tests Not Catching Cancer Recurrence Early Enough
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read More
Algorithms Can Help Predict Undiagnosed Cancer
New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read More
Breakthrough Device Designation Granted for Roche’s VENTANA TROP2 RxDx Device
Roche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.
Read More